Scott Madel Joined Boston Heart in February 2022 as President.


Scott has consistently provided insightful and innovative leadership for organizational turn-around and profitable growth across healthcare. He has launched novel technologies throughout diverse markets and geographies, spanning multiple payer channels and within various product categories for start-ups, market-leaders, and multi-nationals. Bringing broad strategic awareness and real-world solutions-based experience in clinical diagnostics, Scott is passionate about improving the delivery of patient-centric solutions which enable practitioners to address cardiometabolic disease with advanced testing.